<trans-title xml:lang="en"/>_West China Medical Journal

Authors：

, 

四川大学华西医院肾脏内科（成都 610041）;

Corresponding author：

, Email: hzxawy@hotmail.com

Keywords：

恶性高血压; 血栓性微血管病; 急性肾损伤

DOI：

10.7507/1002-0179.201512230

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 张静, 胡章学. . West China Medical Journal, 2017, 32(2): 298-300. doi: 10.7507/1002-0179.201512230 Copy

1.	Volhard F, Fahr T. Die Brightsche Nierenkrankheit: Klinik, Pathologie und Atlas. Berlin: Verlag von Julius Springer, 1914: 247-280.
2.	Kitiyakara C, Guzman J. Malignant hypertension and hypertensive emergencies. J Am Soc Nephrol, 1998, 9(1): 133-142.
3.	Shibagaki Y, Fujita T. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?. Hypertens Res, 2005, 28(1): 89-95.
4.	Zhang B, Xing C, Yu X, et al. Renal thrombotic microangiopathies induced by severe hypertension. Hypertens Res, 2008, 31(3): 479-483.
5.	Barbour T, Johnson S, Cohney S, et al. Thrombotic microangiopathy and associated renal disorders. Nephrol Dial Transplant, 2012, 27(7): 2673-2685.
6.	Moake JL. Thrombotic microangiopathies. N Engl J Med, 2002, 347(8): 589-600.
7.	Akimoto T, Muto S, Ito C, et al. Clinical features of malignant hypertension with thrombotic microangiopathy. Clin Exp Hypertens, 2011, 33(2): 77-83.
8.	van den Born BJ, Koopmans RP, Honnebier U, et al. Microangiopathic hemolysis and renal failure in malignant hypertension. J Hypertens, 2004, 22(2): S79.
9.	Clark WF, Hildebrand A. Attending rounds: microangiopathic hemolytic anemia with renal insufficiency. Clini J Am Soc Nephrol, 2012, 7(2): 342-347.
10.	Benz K, Amann K. Thrombotic microangiopathy: new insights. Curr Opin Nephrol Hypertens, 2010, 19(3): 242-247.
11.	van den Born BJ, van der Hoeven NV, Groot E, et al. Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension. Hypertension, 2008, 51(4): 862-866.
12.	Nzerue C, Oluwole K, Adejorin D, et al. Malignant hypertension with thrombotic microangiopathy and persistent acute kidney injury (AKI). Clin Kidney J, 2014, 7(6): 586-589.
13.	Guerin C, Gonthier R, Berthoux FC. Long-term prognosis in malignant or accelerated hypertension. Nephrol Dial Transplant, 1988, 3(1): 33-37.
14.	Amraoui F, Bos S, Vogt L, et al. Long-term renal outcome in patients with malignant hypertension: a retrospective cohort study. BMC Nephrol, 2012, 13(13): 71.

1. Volhard F, Fahr T. Die Brightsche Nierenkrankheit: Klinik, Pathologie und Atlas. Berlin: Verlag von Julius Springer, 1914: 247-280.
2. Kitiyakara C, Guzman J. Malignant hypertension and hypertensive emergencies. J Am Soc Nephrol, 1998, 9(1): 133-142.
3. Shibagaki Y, Fujita T. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?. Hypertens Res, 2005, 28(1): 89-95.
4. Zhang B, Xing C, Yu X, et al. Renal thrombotic microangiopathies induced by severe hypertension. Hypertens Res, 2008, 31(3): 479-483.
5. Barbour T, Johnson S, Cohney S, et al. Thrombotic microangiopathy and associated renal disorders. Nephrol Dial Transplant, 2012, 27(7): 2673-2685.
6. Moake JL. Thrombotic microangiopathies. N Engl J Med, 2002, 347(8): 589-600.
7. Akimoto T, Muto S, Ito C, et al. Clinical features of malignant hypertension with thrombotic microangiopathy. Clin Exp Hypertens, 2011, 33(2): 77-83.
8. van den Born BJ, Koopmans RP, Honnebier U, et al. Microangiopathic hemolysis and renal failure in malignant hypertension. J Hypertens, 2004, 22(2): S79.
9. Clark WF, Hildebrand A. Attending rounds: microangiopathic hemolytic anemia with renal insufficiency. Clini J Am Soc Nephrol, 2012, 7(2): 342-347.
10. Benz K, Amann K. Thrombotic microangiopathy: new insights. Curr Opin Nephrol Hypertens, 2010, 19(3): 242-247.
11. van den Born BJ, van der Hoeven NV, Groot E, et al. Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension. Hypertension, 2008, 51(4): 862-866.
12. Nzerue C, Oluwole K, Adejorin D, et al. Malignant hypertension with thrombotic microangiopathy and persistent acute kidney injury (AKI). Clin Kidney J, 2014, 7(6): 586-589.
13. Guerin C, Gonthier R, Berthoux FC. Long-term prognosis in malignant or accelerated hypertension. Nephrol Dial Transplant, 1988, 3(1): 33-37.
14. Amraoui F, Bos S, Vogt L, et al. Long-term renal outcome in patients with malignant hypertension: a retrospective cohort study. BMC Nephrol, 2012, 13(13): 71.

West China Medical Journal

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content